Importer of Controlled Substances; Notice of Registration, 9588-9589 [E8-3181]
Download as PDF
<![CDATA[
9588
Federal Register / Vol. 73, No. 35 / Thursday, February 21, 2008 / Notices
investigation by June 6, 2008. In its
January 29, 2008, letter the Committee
extended the time for providing the
report to September 8, 2008. Following
receipt of the Committee’s letter, the
Commission adjusted its internal work
schedule and also extended the
deadline for filing written submissions
relating to the investigation from
February 29, 2008, to May 6, 2008.
The Commission published notice of
institution of the investigation in the
Federal Register on September 19, 2007
(72 FR 53603). The notice is also
available on the Commission Web site at
https://www.usitc.gov. All other
information about the investigation,
including a description of the subject
matter to be addressed, contact
information, procedures for filing
written submissions, and Commission
addresses, remains the same as in the
original notice. The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at: https://www.usitc.gov/secretary/
edis.htm.
Issued: February 14, 2008.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E8–3128 Filed 2–20–08; 8:45 am]
Department of Justice, Washington, DC
20044–7611. In either case, the
comments should refer to United States
v. Cyprus Amax Minerals Co., DOJ Ref.
#90–11–2–1081A.
The proposed consent decree may be
examined at the office of the United
States Attorney, District of Kansas, 1200
Epic Center, 301 N. Main, Wichita, KS
67202. During the public comment
period, the proposed consent decree
may also be examined on this
Department of Justice Web site: https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Consent Decree may also be obtained by
mail from the Consent Decree Library,
P.O. Box 7611, U.S. Department of
Justice, Washington, DC 20044–7611, or
by faxing or e-mailing a request to Tonia
Fleetwood (tonia.fleetwood@usdoj.gov),
fax no. (202) 514–0097, phone
confirmation number (202) 514–1547. In
requesting a copy from the Consent
Decree Library, please enclose a check
in the amount of $6.00 (25 cents per
page reproduction cost) payable to the
United States Treasury or, if by e-mail
or fax, forward a check in that amount
to the Consent Decree Library at the
stated address.
DEPARTMENT OF JUSTICE
BILLING CODE 4410–15–P
Lodging of Consent Decree Under the
Clean Water Act
pwalker on PROD1PC71 with NOTICES
BILLING CODE 7020–02–P
Robert E. Maher, Jr.,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. E8–3140 Filed 2–20–08; 8:45 am]
DEPARTMENT OF JUSTICE
Notice is hereby given that a proposed
Consent Decree in United States of
America; Kansas Department of Health
and Environment; and Roderick L.
Bremby, Secretary, Kansas Department
of Health and Environment v. Cyprus
Amax Minerals Company, Civil Action
No. 08–1046–JTM–DWB, was lodged on
February 13, 2008, with the United
States District Court for the District of
Kansas. The Consent Decree requires
Cyprus Amax Minerals Company to pay
$1,200,000.00 to resolve the claims of
the United States and State of Kansas
under Section 311(f) of the Clean Water
Act, 33 U.S.C. 1321(f), and Kansas state
law for natural resource damages at the
Cherokee County Superfund Site (the
‘‘Site’’).
For thirty (30) days after the date of
this publication, the Department of
Justice will receive comments relating to
the Consent Decree. Comments should
be addressed to the Assistant Attorney
General, Environment and Natural
Resources Division, and either e-mailed
to pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
VerDate Aug<31>2005
16:34 Feb 20, 2008
Jkt 214001
Notice of Lodging of Settlement
Agreement Pursuant to the
Comprehensive Environmental
Response, Compensation, and Liability
Act (‘‘CERCLA’’)
Notice is hereby given that on
February 8, 2008, a proposed Settlement
Agreement in In re Troy Mills,
Incorporated No. 1:01–bk–13341, was
lodged with the United States
Bankruptcy Court for the Northern
District of West Virginia.
On March 19, 2004, the United States,
on behalf of the Environmental
Protection Agency (‘‘EPA’’), filed a Proof
of Claim under Section 107(a) of the
Comprehensive Environmental
Response, Compensation, and Liability
Act, as amended (‘‘CERCLA’’), 42 U.S.C.
9607(a), against the Debtor seeking
recovery of $1,100,838 in past costs,
plus all future costs incurred by EPA in
responding to the release or threat of
release of hazardous substances at the
Troy Mills Superfund Site (‘‘Site’’) in
Troy, New Hampshire. The Settlement
Agreement provides that the United
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
States will have an allowed
administrative claim against the Debtor
in the amount of $14,000,000 and be
allowed to place a lien for this amount
on Debtor’s property at the Site.
Additionally, Troy Mills will provide an
easement to the State of New Hampshire
protecting groundwater and the remedy
at the Site.
The Department of Justice will receive
for a period of thirty (30) days from the
date of this publication comments
relating to the Settlement Agreement.
Comments should be addressed to the
Assistant Attorney General,
Environment and Natural Resources
Division, and either e-mailed to
pubcomment-ees.enrd@usdoj.gov or
mailed to P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611. In either case, the
comments should refer to In re Troy
Mills, Incorporated No. 1:01–bk–13341,
D.J. Ref. 90–11–3–08049.
The Settlement Agreement may be
examined at the Office of the United
States Attorney, Northern District of
West Virginia, P.O. Box 591, Wheeling,
WV 26003–0011 and at U.S. EPA Region
I, One Congress Street, Suite 1100 SES,
Boston, MA 02114–2023 (contact Senior
Enforcement Counsel David Peterson).
During the public comment period, the
Settlement Agreement may also be
examined on the following Department
of Justice Web site, https://
www.usdoj.gov/enrd/
Consent_Decrees.html. A copy of the
Settlement Agreement may also be
obtained by mail from the Consent
Decree Library, P.O. Box 7611, U.S.
Department of Justice, Washington, DC
20044–7611 or by faxing or e-mailing a
request to Tonia Fleetwood
(tonia.fleetwood@usdoj.gov), fax no.
(202) 514–0097, phone confirmation
number (202) 514–1547. In requesting a
copy from the Consent Decree Library,
please enclose a check in the amount of
$2.75 (25 cents per page reproduction
cost) payable to the U.S. Treasury.
Ronald G. Gluck,
Assistant Chief, Environmental, Enforcement
Section, Environment and Natural Resources
Division.
[FR Doc. E8–2954 Filed 2–20–08; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 6, 2007
and published in the Federal Register
on November 16, 2007, (72 FR 64680–
E:\FR\FM\21FEN1.SGM
21FEN1
9589
Federal Register / Vol. 73, No. 35 / Thursday, February 21, 2008 / Notices
64681), JFC Technologies LLC., 100
West Main Street, P.O. Box 669, Bound
Brook, New Jersey 08805, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Meperidine intermediate-B (9233), a
basic class of controlled substance listed
in schedule II.
The company plans to import the
basic class of controlled substance for
the production of controlled substances
for clinical trials, research, analytical
purposes, and distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
JFC Technologies LLC. to import the
basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated JFC
Technologies LLC. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–3181 Filed 2–20–08; 8:45 am]
Drug Enforcement Administration
pwalker on PROD1PC71 with NOTICES
Importer of Controlled Substances;
Notice of Registration
By Notice dated November 5, 2007
and published in the Federal Register
on November 16, 2007, (72 FR 64674),
Aptuit, 10245 Hickman Mills Drive,
Kansas City, Missouri 64137, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Marihuana (7360), a basic class of
controlled substance listed in
schedule I.
Jkt 214001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Importer of Controlled Substances;
Notice of Application
DEPARTMENT OF JUSTICE
16:34 Feb 20, 2008
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–3174 Filed 2–20–08; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
VerDate Aug<31>2005
The company plans to import a
finished pharmaceutical product
containing cannabis extracts in dosage
form for packaging for a clinical trial
study.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Aptuit to import the basic class of
controlled substance is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
has investigated Aptuit to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic class of controlled substance
listed.
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this section to a
bulk manufacturer of a controlled
substance in schedule I or II, and prior
to issuing a registration under 21 U.S.C.
952(a)(2) authorizing the importation of
such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with Title 21
Code of Federal Regulations (CFR),
1301.34(a), this is notice that on January
10, 2008, Sigma Aldrich Manufacturing
LLC., 3500 Dekalb Street, St. Louis,
Missiouri 63118, made application to
the Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedule I and II:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ..................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ...................
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
N-Benzylpiperazine (BZP) (7493)
Trifluoromethylphenyl Piperazine
(7494).
Heroin (9200) ...............................
Normorphine (9313) .....................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ...................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium powdered (9639) ..............
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
E:\FR\FM\21FEN1.SGM
21FEN1
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
]]>Agencies
[Federal Register Volume 73, Number 35 (Thursday, February 21, 2008)]
[Notices]
[Pages 9588-9589]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3181]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated November 6, 2007 and published in the Federal
Register on November 16, 2007, (72 FR 64680-
[[Page 9589]]
64681), JFC Technologies LLC., 100 West Main Street, P.O. Box 669,
Bound Brook, New Jersey 08805, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of
Meperidine intermediate-B (9233), a basic class of controlled substance
listed in schedule II.
The company plans to import the basic class of controlled substance
for the production of controlled substances for clinical trials,
research, analytical purposes, and distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of JFC Technologies LLC. to import the basic class of
controlled substance is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
JFC Technologies LLC. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34,
the above named company is granted registration as an importer of the
basic class of controlled substance listed.
Dated: February 12, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-3181 Filed 2-20-08; 8:45 am]
BILLING CODE 4410-09-P
